Laboratorios Farmaceuticos Rovi S.A. ROVI
Dividend Summary
The next Laboratorios Farmaceuticos Rovi S.A. dividend is expected to go ex in 7 months and to be paid in 7 months.
The previous Laboratorios Farmaceuticos Rovi S.A. dividend was 110.37¢ and it went ex 6 months ago and it was paid 5 months ago.
There is typically 1 dividend per year (excluding specials), and the dividend cover is approximately 2.0.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | Forecast |
| Type | Final | Final |
| Per share | 110.37¢ | Sign Up Required |
| Declaration date | 27 Feb 2024 (Tue) | 25 Feb 2025 (Tue) |
| Ex-div date | 08 Jul 2024 (Mon) | 07 Jul 2025 (Mon) |
| Pay date | 10 Jul 2024 (Wed) | 09 Jul 2025 (Wed) |
Enter the number of Laboratorios Farmaceuticos Rovi S.A. shares you hold and we'll calculate your dividend payments:
Sign up for Laboratorios Farmaceuticos Rovi S.A. and we'll email you the dividend information when they declare.
Add Laboratorios Farmaceuticos Rovi S.A. to receive free notifications when they declare their dividends.
Your account is set up to receive Laboratorios Farmaceuticos Rovi S.A. notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Forecast | Final | 20 Feb 2029 | 02 Jul 2029 | 04 Jul 2029 | EUR | Sign up | — | |
| Forecast | Final | 22 Feb 2028 | 03 Jul 2028 | 05 Jul 2028 | EUR | Sign up | — | |
| Forecast | Final | 23 Feb 2027 | 05 Jul 2027 | 07 Jul 2027 | EUR | Sign up | — | |
| Forecast | Final | 24 Feb 2026 | 06 Jul 2026 | 08 Jul 2026 | EUR | Sign up | — | |
| Forecast | Final | 25 Feb 2025 | 07 Jul 2025 | 09 Jul 2025 | EUR | Sign up | — | |
| Paid | Final | 27 Feb 2024 | 08 Jul 2024 | 10 Jul 2024 | EUR | 168¢ | 110.37¢ | 😓 |
| Paid | Final | – | 03 Jul 2023 | 05 Jul 2023 | EUR | 124¢ | 129.38¢ | 😃 |
| Paid | Final | – | 05 Jul 2022 | 07 Jul 2022 | EUR | — | 95.56¢ | |
| Paid | Final | – | 05 Jul 2021 | 07 Jul 2021 | EUR | — | 38.12¢ | |
| Paid | Final | – | 17 Nov 2020 | 19 Nov 2020 | EUR | — | 17.51¢ | |
| Paid | Final | – | 02 Jul 2019 | 04 Jul 2019 | EUR | — | 7.98¢ | |
| Paid | Final | – | 03 Jul 2018 | 05 Jul 2018 | EUR | — | 12.07¢ | |
| Paid | Final | – | 03 Jul 2017 | 05 Jul 2017 | EUR | — | 18.3¢ | |
| Paid | Final | – | 30 Jun 2016 | 05 Jul 2016 | EUR | — | 13.9¢ | |
| Paid | Final | – | 02 Jul 2015 | 02 Jul 2015 | EUR | — | 16.9¢ | |
| Paid | Final | – | 03 Jul 2014 | 03 Jul 2014 | EUR | — | 16.12¢ | |
| Paid | Final | – | 03 Jul 2013 | 03 Jul 2013 | EUR | — | 13.66¢ |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0¢ | — |
| 2007 | 0.0¢ | 0% |
| 2008 | 0.0¢ | 0% |
| 2009 | 0.0¢ | 0% |
| 2010 | 0.0¢ | 0% |
| 2011 | 0.0¢ | 0% |
| 2012 | 13.66¢ | 100% |
| 2013 | 16.12¢ | 18.0% |
| 2014 | 16.9¢ | 4.8% |
| 2015 | 13.9¢ | -17.8% |
| 2016 | 18.3¢ | 31.7% |
| 2017 | 12.07¢ | -34.0% |
| 2018 | 7.98¢ | -33.9% |
| 2019 | 17.51¢ | 119.4% |
| 2020 | 38.12¢ | 117.7% |
| 2021 | 95.56¢ | 150.7% |
| 2022 | 129.38¢ | 35.4% |
| 2023 | 110.37¢ | -14.7% |
| 2024 | Sign Up Required | |
| 2025 | Sign Up Required | |
| 2026 | Sign Up Required | |
| 2027 | Sign Up Required | |
| 2028 | Sign Up Required | |
Laboratorios Farmaceuticos Rovi S.A. Optimized Dividend Chart
- Dividend Yield Today
- 2.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 4.0% on 29 January 2024
- 52 Week Low
- 1.4% on 31 July 2024
- Next Ex-Div-Date Countdown
- Sign Up Required
About Laboratorios Farmaceuticos Rovi S.A.
Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- Spain
- Share Price
- €61.40 (yesterday's closing price)
- Shares in Issue
- 51 million
- Market Cap
- €3.1bn
- 2.0
- 0
- Market Indices
- none
